|
⚲
|
| Keyboard |
| Venrock Associates VII LP
✚
|
|
|---|---|
| CIK # | 0001614766 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001614766] | |
| 4 | [0001614766] | |
| D | [0001614766] | |
| SC 13G | [0001614766] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Venrock Associates VII LP | Cyteir Therapeutics Inc | [2022-02-14] |
| Venrock Associates VII LP | Unity Biotechnology Inc | [2019-02-14] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cyteir Therapeutics Inc CYT
Common Stock
|
2021-06-22 | Conversion | 3,259,025 | ||
|
Cyteir Therapeutics Inc CYT
Series B Convertible Preferred Stock · derivative
|
2021-06-22 | Conversion | 10,000,000 | ||
|
Cyteir Therapeutics Inc CYT
Series C Convertible Preferred Stock · derivative
|
2021-06-22 | Conversion | 1,109,368 | ||
|
Shockwave Medical Inc SWAV
Common Stock
|
2019-03-11 | Conversion | 1,016,492 | ||
|
Shockwave Medical Inc SWAV
Series B Convertible Preferred Stock · derivative
|
2019-03-11 | Conversion | 1,105,529 | ||
|
Shockwave Medical Inc SWAV
Common Stock
|
2019-03-11 | Conversion | 1,105,529 | ||
|
Shockwave Medical Inc SWAV
Series C Convertible Preferred Stock · derivative
|
2019-03-11 | Conversion | 1,016,492 |